📷 Image: Wikimedia Commons / Harvinder Chandigarh
Health
Himachal Pradesh drug regulator orders halt to production at Sirmaur unit
✍️ The Times of India
🗓 10 Sep 2026, 12:17 AM
👁 30
The Himachal Pradesh drug regulatory authority has directed a pharmaceutical unit in Sirmaur district to cease production, as reported by The Times of India.
The Himachal Pradesh State Drug Control Department issued an order on [date not provided] directing a manufacturing unit located in Sirmaur district to stop all production activities. The directive, reported by The Times of India, comes as part of the regulator’s routine oversight to ensure compliance with safety and quality standards.
The order mandates that the unit suspend operations until it receives clearance after a detailed inspection. Officials have not disclosed the specific reasons for the halt, but such actions are typically taken when there are concerns about manufacturing practices, product quality, or regulatory non‑compliance.
The regulatory body has advised the unit to cooperate fully with the inspection team and to address any deficiencies identified. The halt is expected to affect the unit’s output temporarily, with the possibility of resumption once compliance is verified.
No further details regarding the scale of production or the types of drugs manufactured were released at this stage.
The order mandates that the unit suspend operations until it receives clearance after a detailed inspection. Officials have not disclosed the specific reasons for the halt, but such actions are typically taken when there are concerns about manufacturing practices, product quality, or regulatory non‑compliance.
The regulatory body has advised the unit to cooperate fully with the inspection team and to address any deficiencies identified. The halt is expected to affect the unit’s output temporarily, with the possibility of resumption once compliance is verified.
No further details regarding the scale of production or the types of drugs manufactured were released at this stage.